title: When Does ALS Start? ADAR2-GluA2 Hypothesis for the Etiology of Sporadic ALS.
abstract: Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease. More than 90% of ALS cases are sporadic, and the majority of sporadic ALS patients do not carry mutations in genes causative of familial ALS; therefore, investigation specifically targeting sporadic ALS is needed to discover the pathogenesis. The motor neurons of sporadic ALS patients express unedited GluA2 mRNA at the Q/R site in a disease-specific and motor neuron-selective manner. GluA2 is a subunit of the AMPA receptor, and it has a regulatory role in the Ca(2+)-permeability of the AMPA receptor after the genomic Q codon is replaced with the R codon in mRNA by adenosine-inosine conversion, which is mediated by adenosine deaminase acting on RNA 2 (ADAR2). Therefore, ADAR2 activity may not be sufficient to edit all GluA2 mRNA expressed in the motor neurons of ALS patients. To investigate whether deficient ADAR2 activity plays pathogenic roles in sporadic ALS, we generated genetically modified mice (AR2) in which the ADAR2 gene was conditionally knocked out in the motor neurons. AR2 mice showed an ALS-like phenotype with the death of ADAR2-lacking motor neurons. Notably, the motor neurons deficient in ADAR2 survived when they expressed only edited GluA2 in AR2/GluR-B(R/R) (AR2res) mice, in which the endogenous GluA2 alleles were replaced by the GluR-B(R) allele that encoded edited GluA2. In heterozygous AR2 mice with only one ADAR2 allele, approximately 20% of the spinal motor neurons expressed unedited GluA2 and underwent degeneration, indicating that half-normal ADAR2 activity is not sufficient to edit all GluA2 expressed in motor neurons. It is likely therefore that the expression of unedited GluA2 causes the death of motor neurons in sporadic ALS. We hypothesize that a progressive downregulation of ADAR2 activity plays a critical role in the pathogenesis of sporadic ALS and that the pathological process commences when motor neurons express unedited GluA2.
authors.affiliation: Core Research for Evolutional Science and Technology, Japan Science Technology Agency Kawaguchi-shi, Saitama, Japan.
authors.forename: Takuto
authors.initials: T
authors.lastname: Hideyama
authors.forename: Shin
authors.initials: S
authors.lastname: Kwak
references.citation: Ann Neurol. 2008 Jul;64(1):60-70
references.pmid: 18546284
references.citation: J Neurosci. 1993 Dec;13(12):5009-28
references.pmid: 8254358
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13777-82
references.pmid: 9811877
references.citation: Neurosci Res. 2006 Jan;54(1):11-4
references.pmid: 16225946
references.citation: Science. 2008 Mar 21;319(5870):1668-72
references.pmid: 18309045
references.citation: Nature. 2004 Feb 26;427(6977):801
references.pmid: 14985749
references.citation: Nihon Yakurigaku Zasshi. 2003 Dec;122(6):515-26
references.pmid: 14639006
references.citation: Trends Neurosci. 2010 May;33(5):249-58
references.pmid: 20227117
references.citation: Ann Neurol. 1997 Nov;42(5):803-7
references.pmid: 9392581
references.citation: Science. 2006 Oct 6;314(5796):130-3
references.pmid: 17023659
references.citation: Neuroscience. 2011 Aug 25;189:305-15
references.pmid: 21620933
references.citation: Cell. 1991 Oct 4;67(1):11-9
references.pmid: 1717158
references.citation: Neuron. 2002 May 30;34(5):759-72
references.pmid: 12062022
references.citation: Acta Neuropathol. 2010 Jul;120(1):75-84
references.pmid: 20372915
references.citation: Neurosci Res. 2008 Jun;61(2):201-6
references.pmid: 18407364
references.citation: Nature. 1996 Feb 1;379(6564):460-4
references.pmid: 8559253
references.citation: Science. 2009 Feb 27;323(5918):1208-1211
references.pmid: 19251628
references.citation: Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11
references.pmid: 17084815
references.citation: Science. 2000 Dec 1;290(5497):1765-8
references.pmid: 11099415
references.citation: Nature. 1993 Mar 4;362(6415):59-62
references.pmid: 8446170
references.citation: Nat Genet. 2008 May;40(5):572-4
references.pmid: 18372902
references.citation: Neuroreport. 1994 Aug 15;5(13):1679-83
references.pmid: 7529592
references.citation: Cell. 1993 Dec 31;75(7):1361-70
references.pmid: 8269514
references.citation: Acta Neuropathol. 2007 May;113(5):535-42
references.pmid: 17333220
references.citation: Science. 1995 Dec 8;270(5242):1677-80
references.pmid: 7502080
references.citation: Nature. 2000 Jul 6;406(6791):78-81
references.pmid: 10894545
references.citation: Science. 2009 Feb 27;323(5918):1205-8
references.pmid: 19251627
references.citation: Ann Neurol. 2010 Jun;67(6):739-48
references.pmid: 20517935
references.citation: J Neurosci. 2010 Sep 8;30(36):11917-25
references.pmid: 20826656
references.citation: Ann Neurol. 2008 Apr;63(4):538-42
references.pmid: 18438952
references.citation: Neurosci Res. 2005 Jul;52(3):228-34
references.pmid: 15927724
references.citation: Neuron. 1995 Jul;15(1):193-204
references.pmid: 7619522
references.citation: J Mol Med (Berl). 2005 Feb;83(2):110-20
references.pmid: 15624111
references.citation: Genesis. 2003 Sep;37(1):44-50
references.pmid: 14502577
references.citation: J Neurochem. 1994 Nov;63(5):1596-602
references.pmid: 7523595
references.citation: PLoS One. 2009 Dec 14;4(12):e8210
references.pmid: 20011587
references.citation: Brain Res. 1995 Nov 20;699(2):297-304
references.pmid: 8616634
references.citation: J Neurochem. 2003 May;85(3):680-9
references.pmid: 12694394
references.citation: Neuropathol Appl Neurobiol. 1993 Aug;19(4):291-9
references.pmid: 8232749
references.citation: Exp Neurol. 2002 Apr;174(2):150-61
references.pmid: 11922657
references.citation: Mech Ageing Dev. 2010 Jun;131(6):445-7
references.pmid: 20538013
references.citation: Ann Neurol. 1999 Dec;46(6):806-15
references.pmid: 10589532
references.citation: Lancet Neurol. 2008 May;7(5):409-16
references.pmid: 18396105
references.citation: Ann Neurol. 2007 May;61(5):427-34
references.pmid: 17469116